Clinical Trials Browser

Terminated × INDUSTRY × donafenib × Clear all

NCT02489201 2023-06-15

A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer

Phase 1/2 Terminated

Gastrointestinal

Esophageal Neoplasms

NCT04402723 2022-12-01

Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03602495 2021-12-13

DTC

Phase 3 Terminated

EndocrineHead & Neck

Differentiated Thyroid Cancer